Literature DB >> 17537854

Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.

Morgane Rolland1, Mark A Jensen, David C Nickle, Jian Yan, Gerald H Learn, Laura Heath, David Weiner, James I Mullins.   

Abstract

The extensive diversity of human immunodeficiency virus type 1 (HIV-1) and its capacity to mutate and escape host immune responses are major challenges for AIDS vaccine development. Ancestral sequences, which minimize the genetic distance to circulating strains, provide an opportunity to design immunogens with the potential to elicit broad recognition of HIV epitopes. We developed a phylogenetics-informed algorithm to reconstruct ancestral HIV sequences, called Center of Tree (COT). COT sequences have potentially significant benefits over isolate-based strategies, as they minimize the evolutionary distances to circulating strains. COT sequences are designed to surmount the potential pitfalls stemming from sampling bias with the consensus method and outlier bias with the most-recent-common-ancestor approach. We computationally derived COT sequences from circulating HIV-1 subtype B sequences for the genes encoding the major viral structural protein (Gag) and two regulatory proteins, Tat and Nef. COT genes were synthesized de novo and expressed in mammalian cells, and the proteins were characterized. COT Gag was shown to generate virus-like particles, while COT Tat transactivated gene expression from the HIV-1 long terminal repeat and COT Nef mediated downregulation of cell surface major histocompatibility complex class I. Thus, retrodicted ancestral COT proteins can retain the biological functions of extant HIV-1 proteins. Additionally, COT proteins were immunogenic, as they elicited antigen-specific cytotoxic T-lymphocyte responses in mice. These data support the utility of the COT approach to create novel and biologically active ancestral proteins as a starting point for studies of the structure, function, and biological fitness of highly variable genes, as well as for the rational design of globally relevant vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537854      PMCID: PMC1951385          DOI: 10.1128/JVI.02683-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates.

Authors:  Jianzhi Zhang; Helene F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 2.  Planetary biology--paleontological, geological, and molecular histories of life.

Authors:  Steven A Benner; M Daniel Caraco; J Michael Thomson; Eric A Gaucher
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

3.  Inferring the palaeoenvironment of ancient bacteria on the basis of resurrected proteins.

Authors:  Eric A Gaucher; J Michael Thomson; Michelle F Burgan; Steven A Benner
Journal:  Nature       Date:  2003-09-18       Impact factor: 49.962

4.  Inferring the historical patterns of biological evolution.

Authors:  M Pagel
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

5.  De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Xu G Yu; Elizabeth T Kalife; Laura L Reyor; Mathias Lichterfeld; Mina John; Michael Cheng; Rachel L Allgaier; Stanley Mui; Nicole Frahm; Galit Alter; Nancy V Brown; Mary N Johnston; Eric S Rosenberg; Simon A Mallal; Christian Brander; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 6.  Regulatory and accessory HIV-1 proteins: potential targets for HIV-1 vaccines?

Authors:  X G Yu; M Lichterfeld; M M Addo; M Altfeld
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

7.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.

Authors:  N A Doria-Rose; G H Learn; A G Rodrigo; D C Nickle; F Li; M Mahalanabis; M T Hensel; S McLaughlin; P F Edmonson; D Montefiori; S W Barnett; N L Haigwood; J I Mullins
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

Authors:  Punnee Pitisuttithum; Sorachai Nitayaphan; Prasert Thongcharoen; Chirasak Khamboonruang; Jerome Kim; Mark de Souza; Thippawan Chuenchitra; Robin P Garner; Darawan Thapinta; Victoria Polonis; Silvia Ratto-Kim; Penprapa Chanbancherd; Joseph Chiu; Deborah L Birx; Anne-Marie Duliege; John G McNeil; Arthur E Brown
Journal:  J Infect Dis       Date:  2003-07-03       Impact factor: 5.226

Review 10.  Diversity considerations in HIV-1 vaccine selection.

Authors:  Brian Gaschen; Jesse Taylor; Karina Yusim; Brian Foley; Feng Gao; Dorothy Lang; Vladimir Novitsky; Barton Haynes; Beatrice H Hahn; Tanmoy Bhattacharya; Bette Korber
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  33 in total

1.  FastML: a web server for probabilistic reconstruction of ancestral sequences.

Authors:  Haim Ashkenazy; Osnat Penn; Adi Doron-Faigenboim; Ofir Cohen; Gina Cannarozzi; Oren Zomer; Tal Pupko
Journal:  Nucleic Acids Res       Date:  2012-05-31       Impact factor: 16.971

Review 2.  T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.

Authors:  Bette T Korber; Norman L Letvin; Barton F Haynes
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

3.  High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.

Authors:  Alleluiah Rutebemberwa; Stuart C Ray; Jacquie Astemborski; Jordana Levine; Lin Liu; Kimberly A Dowd; Shalyn Clute; Changyu Wang; Alan Korman; Alessandro Sette; John Sidney; Drew M Pardoll; Andrea L Cox
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.

Authors:  Sampa Santra; Bette T Korber; Mark Muldoon; Dan H Barouch; Gary J Nabel; Feng Gao; Beatrice H Hahn; Barton F Haynes; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

5.  HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.

Authors:  Morgane Rolland; Siriphan Manocheewa; J Victor Swain; Erinn C Lanxon-Cookson; Moon Kim; Dylan H Westfall; Brendan B Larsen; Peter B Gilbert; James I Mullins
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.

Authors:  Robert T Chen; Dale J Hu; Eileen Dunne; Michael Shaw; James I Mullins; Supachai Rerks-Ngarm
Journal:  Vaccine       Date:  2011-07-13       Impact factor: 3.641

7.  Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.

Authors:  Jian Yan; Kristina Harris; Amir S Khan; Ruxandra Draghia-Akli; Duane Sewell; David B Weiner
Journal:  Vaccine       Date:  2008-04-14       Impact factor: 3.641

8.  Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.

Authors:  Krystle A Lang; Jian Yan; Ruxandra Draghia-Akli; Amir Khan; David B Weiner
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

9.  Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.

Authors:  Zabrina L Brumme; Chanson J Brumme; Jonathan Carlson; Hendrik Streeck; Mina John; Quentin Eichbaum; Brian L Block; Brett Baker; Carl Kadie; Martin Markowitz; Heiko Jessen; Anthony D Kelleher; Eric Rosenberg; John Kaldor; Yuko Yuki; Mary Carrington; Todd M Allen; Simon Mallal; Marcus Altfeld; David Heckerman; Bruce D Walker
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

10.  Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination.

Authors:  Wing-Pui Kong; Lan Wu; Timothy C Wallstrom; Will Fischer; Zhi-Yong Yang; Sung-Youl Ko; Norman L Letvin; Barton F Haynes; Beatrice H Hahn; Bette Korber; Gary J Nabel
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.